HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiichiro Nishida Selected Research

Pain (Aches)

1/2022Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis.
12/2019The factors driving self-efficacy in intractable chronic pain patients: a retrospective study.
8/2018A Multidisciplinary Approach to the Management of Chronic Pain through a Self-managed Behavioral Exercise Program : A Pilot Study in Japan.
5/2017Short-term outcomes of patients being treated for chronic intractable pain at a liaison clinic and exacerbating factors of prolonged pain after treatment.
3/2017Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures.
6/2016[Recent advances in upper extremity surgery for rheumatoid arthritis].
1/2016Effect of Tramadol/Acetaminophen on Motivation in Patients with Chronic Low Back Pain.
1/2014A 5-22-year follow-up study of stemmed alumina ceramic total elbow arthroplasties with cement fixation for patients with rheumatoid arthritis.
6/2010Preoperative time required for the timed "up and go" test in women with hip osteoarthritis could predict a deep venous thrombosis complication after total hip arthroplasty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiichiro Nishida Research Topics

Disease

41Rheumatoid Arthritis
10/2022 - 01/2004
9Inflammation (Inflammations)
02/2022 - 10/2004
9Pain (Aches)
01/2022 - 06/2010
9Osteoarthritis
03/2021 - 10/2007
8Arthritis (Polyarthritis)
02/2022 - 02/2003
5Major Depressive Disorder (Major Depressive Disorders)
10/2022 - 01/2017
4Surgical Wound Infection
02/2022 - 11/2011
4Neoplasms (Cancer)
01/2010 - 01/2002
4Chondrosarcoma
05/2005 - 01/2002
3Infections
02/2022 - 11/2011
3Congenital Abnormalities (Deformity)
01/2022 - 12/2016
3Schizophrenia (Dementia Praecox)
01/2016 - 01/2013
3Venous Thrombosis (Deep-Vein Thrombosis)
06/2010 - 01/2002
2Necrosis
03/2022 - 05/2015
2Diabetes Mellitus
02/2022 - 04/2007
2Sleep Initiation and Maintenance Disorders (Insomnia)
09/2021 - 01/2019
2Sleepiness
05/2020 - 01/2017
2Hypertrophy
01/2019 - 01/2009
2Disease Progression
11/2018 - 06/2017
2Wounds and Injuries (Trauma)
08/2015 - 01/2004
2Synovitis
01/2015 - 01/2002
1Chronic Obstructive Pulmonary Disease (COPD)
02/2022
1Chronic Pain
09/2021
1Hypoxia (Hypoxemia)
01/2021
1Nutrition Disorders (Nutritional Disorders)
01/2021
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2021
1Edema (Dropsy)
05/2020
1Dizziness (Lightheadedness)
05/2020
1Neuralgia (Stump Neuralgia)
05/2020
1Weight Gain
05/2020

Drug/Important Bio-Agent (IBA)

7Biological ProductsIBA
02/2022 - 11/2011
7Antirheumatic Agents (DMARD)IBA
02/2022 - 11/2011
6CytokinesIBA
03/2022 - 01/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2018 - 05/2005
4Pharmaceutical PreparationsIBA
03/2022 - 01/2013
4CollagenIBA
02/2022 - 04/2002
3TeaIBA
10/2022 - 01/2014
3EnzymesIBA
03/2022 - 07/2004
3Interleukin-6 (Interleukin 6)IBA
03/2022 - 05/2018
34-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
09/2021 - 05/2017
3LigandsIBA
01/2021 - 03/2017
3AutoantibodiesIBA
03/2015 - 02/2003
2Mirtazapine (Rexer)FDA LinkGeneric
10/2022 - 01/2017
2Certolizumab PegolFDA Link
07/2022 - 01/2017
2Antidepressive Agents (Antidepressants)IBA
03/2022 - 01/2017
2MicroRNAs (MicroRNA)IBA
03/2022 - 01/2021
2ImmunosorbentsIBA
03/2022 - 04/2011
2InterleukinsIBA
03/2022 - 05/2015
2Lymphotoxin-alpha (Lymphotoxin)IBA
01/2021 - 06/2018
2C-Reactive ProteinIBA
01/2021 - 04/2007
2Hyaluronic Acid (Hyaluronan)IBA
04/2020 - 12/2018
2Abatacept (Orencia)FDA Link
01/2020 - 05/2014
2A-factor (Streptomyces)IBA
06/2017 - 05/2017
2Aluminum Oxide (Sapphire)IBA
02/2017 - 01/2014
2Paliperidone PalmitateFDA Link
01/2016 - 01/2016
2Risperidone (Risperdal Consta)FDA LinkGeneric
01/2016 - 01/2016
2Monoclonal AntibodiesIBA
05/2015 - 02/2003
2Etanercept (Enbrel)FDA Link
08/2012 - 12/2010
2Collagen Type II (Type II Collagen)IBA
06/2011 - 02/2003
2Histone Deacetylases (Histone Deacetylase)IBA
01/2010 - 10/2004
2Aggrecans (Aggrecan)IBA
01/2009 - 05/2005
2Interleukin-1beta (Interleukin 1 beta)IBA
05/2008 - 05/2005
2fibrin fragment D (D-dimer)IBA
01/2008 - 01/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006 - 01/2002
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2002 - 01/2002
1Interleukin-2 (IL2)IBA
03/2022
1Interleukin-8 (Interleukin 8)IBA
03/2022
1Interleukin-4 (Interleukin 4)IBA
03/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2022
1Therapeutic UsesIBA
02/2022
1Brentuximab VedotinIBA
02/2022
1Biosimilar PharmaceuticalsIBA
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1mirogabalinIBA
05/2020
1Pregabalin (Lyrica)FDA Link
05/2020
1Calcium Channels (Calcium Channel)IBA
05/2020
1Metalloproteases (Metalloproteinases)IBA
10/2019
1ThrombospondinsIBA
10/2019
1Matrix Metalloproteinases (MMPs)IBA
10/2019
1DisintegrinsIBA
10/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Collagen Type XIBA
01/2019
1tofacitinibIBA
11/2018

Therapy/Procedure

8Arthroplasty
10/2022 - 01/2002
8Orthopedic Procedures
02/2022 - 12/2010
5Therapeutics
02/2022 - 01/2002
4Aftercare (After-Treatment)
08/2018 - 12/2010
3Replacement Arthroplasty
01/2022 - 06/2016
3Knee Replacement Arthroplasty (Total Knee Replacement)
03/2021 - 01/2002
3Elbow Prosthesis
02/2017 - 01/2014
2Transcranial Direct Current Stimulation
07/2022 - 01/2019
2Operative Surgical Procedures
01/2022 - 11/2011
2Osteotomy
12/2019 - 12/2016
2Drug Therapy (Chemotherapy)
06/2017 - 03/2017
2Arthrodesis
01/2016 - 01/2004
1Operative Time
02/2022
1Exercise Therapy (Therapy, Exercise)
01/2022
1Activities of Daily Living (ADL)
09/2021
1Punctures
01/2021